Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor

American Journal of Pathology

Volumn 162, Issue 6, 2003, Pages 1995-2004

  El Remessy, Azza B ^a   Ali Behzadian, M ^a   Abou Mohamed, Gamal ^a   Franklin, Telina ^a   Caldwell, Robert W ^a   Caldwell, Ruth B ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; LIPID PEROXIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; TYROSINE; URIC ACID; UROKINASE RECEPTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENZYME ACTIVITY; HYPERGLYCEMIA; MEMBRANE PERMEABILITY; NITRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; VASCULAR DISEASE;

EID: 0038243821     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64332-5     Document Type: Article

References (58)

1. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW: Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content. Diabetes 1998, 47:1953-1959
2. Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994, 118:445-450
3. Qaum T, Xu Q, Houssen A, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP: VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 2001, 42:2408-2413
4. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994, 331:1480-1487
5. Takeda M, Mori F, Yoshida A, Takamiya A, Nakagomi S, Sato E, Kiyama H: Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats. Diabetologia 2001, 44: 1043-1050
6. Joussen AM, Poulaki V, Tsujikawa A, Qin W, Qaum T, Xu Q, Moromizato Y, Bursell SE, Wiegand SJ, Rudge J, Ioffe E, Yancopoulos GD, Adamis AP: Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol 2002, 160:1683-1693
7. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790
8. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 1998, 47:859-866
9. Nakamura N, Obayashi H, Fujii M: Induction of aldose reductase in cultured human microvascular endothelial cells by advanced glycation end products. Free Radic Biol Med 2000, 29:17-25
10. Kossenjans W, Eis A, Sahay R, Brockman D, Myatt L: Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Physiol 2000, 278:H1311-H1319
11. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C: Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 2001, 44:834-838
12. Armstrong D, Al-Awadi F: Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. Free Radic Biol Med 1991, 11:433-436
13. Fathallah L, Obrosova IG: Increased retinal lipid peroxidation in early diabetes is not associated with ascorbate depletion or changes in ascorbate redox state. Exp Eye Res 2001, 72:719-723
14. Cosentino F, Hishikawa K, Katusic SZ, Luscher TF: High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997, 96: 25-28
15. Graier WF, Simecek S, Kukovetz WR, Kostner GM: High D-glucoseinduced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions. Diabetes 1996, 45:1386-1395
16. Graier WF, Posch K, Fleischhacker E, Wascher TC, Kostner GM: Increased superoxide anion formation in endothelial cells during hyperglycemia: an adaptive response or initial step of vascular dysfunction? Diabetes Res Clin Pract 1999, 2-3:153-160
17. Pieper GM, Langenstroer P, Siebeneich W: Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res 1997, 34:145-156
18. Salgo G, Bermudez E, Squadrito L, Pryor A: Peroxynitrite causes DNA damage and oxidation of thiols in rat thymocytes. Arch Biochem Biophys 1995, 322:500-505
19. Salvemini D, Wang Z, Stern M, Currie M, Misko T: Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc Natl Acad Sci USA 1998, 95:2695-2663
20. Milstien S, Katusic Z: Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 1999, 263:681-684
21. Patel JM, Abeles AJ, Block ER: Nitric oxide exposure and sulfhydryl modulation alter L-arginine transport in cultured pulmonary artery endothelial cells. Free Radic Biol Med 1996, 20:629-637
22. Zou MH, Shi C, Cohen RA: Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 2002, 109:817-826
23. El-Remessy AB, Abou-Mohamed G, Caldwell RW, Caldwell RB: High glucose increases tyrosine nitration and superoxide anion formation in endothelial cells. Invest Ophthalmol Vis Sci (In press)
24. Behzadian MA, Windsor JL, Ghaly N, Liou GI, Tsai N, Caldwell RB: VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor. FASEB J. 2003, 17:752-754
25. Mandriota SJ, Seghezzi G, Vassalli JD, Ferrara N, Wasi S, Mazzieri R, Mignatti P, Pepper MS: Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 1995, 270:9709-9716
26. Bredt DS, Snyder SH: Isolation of nitric oxide synthase, a calmodulinrequiring enzyme. Proc Natl Acad Sci USA 1990, 87:682-689
27. Ohkawa H Ohishi N, Yagi K: Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358
28. Brooks SE, Gu X, Samuel S, Marcus DM, Bartoli M, Huang PL, Caldwell RB: Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. Invest Ophthalmol Vis Sci 2001, 42:222-228
29. Misko TP, Highkin MK, Veenhuizen AW, Manning PT, Stern MK, Currie MG, Salvemini D: Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J Biol Chem 1998, 273:15646-15653
30. Viera L, Ye Y, Estevez AG, Beckman JS: Immunohistochemical methods to detect nitrotyrosine. Methods Enzymol 1999, 301:373-381
31. Rabbani SA, Rajwans N, Achbarou A, Murthy KK, Goltzman D: Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts. FEBS Lett 1994, 338:69-74
32. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309
33. Carmo A, Lopes C, Santos M, Proenca R, Cunha-Vaz J, Carvalho AP: Nitric oxide synthase activity and L-arginine metabolism in the retinas from streptozotocin-induced diabetic rats. Gen Pharmacol 1998, 30: 319-324
34. Ischiropoulos H: Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998, 356:1-11
35. Sawa T, Akaike T, Maeda H: Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxidase. J Biol Chem 2000, 275:32467-32474
36. Zhang H, Joseph J, Feix J, Hogg N, Kalyanaraman B: Nitration and oxidation of a hydrophobic tyrosine probe by peroxynitrite in membranes: comparison with nitration and oxidation of tyrosine by peroxynitrite in aqueous solution. Biochemistry 2001, 40:7675-7686
37. Menconi MJ, Unno N, Smith M, Aguirre DE, Fink MP: Nitric oxide donor-induced hyperpermeability of cultured intestinal epithelial monolayers: role of superoxide radical, hydroxyl radical and peroxynitrite. Biochem Biophys Acta 1998, 1425:189-203
38. Mayhan WG: Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain Res 2000, 866:101-108
39. Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM, Chaudhry I, Koprowski H: Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 1998, 95:675-680
40. Whiteman M, Halliwell B: Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants. Free Radic Res 1996, 25:275-283
41. Zazgornik J, Biesenbach G, Janko O, Grafinger P, Kaiser W, Stuby U, Hubmann R: Serum uric acid level in type 1 and type 2 diabetic patients. Wien Med Wochenschr 1996, 146:102-144
42. Kaesemeyer WH, Ogonowski AA, Jin L, Caldwell RB, Caldwell RW: Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate. Br J Pharmacol 2000, 131:1019-1023
43. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW: Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998, 102: 783-791
44. Enea NA, Hollis TM, Kern JA, Gardner TW: Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes. Arch Ophthalmol 1989, 107:270-274
45. Engler C, Krosgaa B, Lund-Anderson H: Blood-retinal barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetes: a 8-year follow-up study. Graefe's Arch Clin Exp Ophthalmol 1991, 229:442-446
46. Gilbert RE, Vranes D, Berka JL, Kelly DJ, Cox A, Wu LL, Stacker SA, Cooper ME: Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest 1998, 78:1017-1027
47. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA: Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995, 113:1538-1544
48. Duh E, Aiello LP: Vascular endothelial growth factor and diabetes. The agonist versus antagonist paradox. Diabetes 1999, 48:1899-1906
49. Tilton RG, Kawamura T, Chang KC, Ido Y, Bjercke RJ, Stephan CC, Brock TA, Williamson JR: Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest 1997, 99:2192-2202
50. Hammes HP, Lin J, Bretzel RG, Brownlee M, Breier G: Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 1998, 47:401-406
51. Peer J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E: Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 1995, 72:638-645
52. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH: Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995, 92:905-909
53. Smith LEH, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994, 35:101-111
54. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, Kim RY, Rohan RM, Colby KA, Yeo KT, Adamis AP: Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 1996, 98:1675-1677
55. 2 sensing. J Biol Chem 2000, 275: 25130-25138
56. Duyndam MC, Hulscher, Fontijn D, Pinedo HM, Boven E: Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1 α protein by the oxidative stressor arsenite. J Biol Chem 2001, 276:48066-48076
57. Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP Kietzmann T, Busse R: Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22phox-containing NADPH oxidase. Circ Res 2001, 89:47-54
58. Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP: Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 1999, 96:10836-10841